LSA
AUPH icon

Leonteq Securities AG’s Aurinia Pharmaceuticals AUPH Stock Holding History

Leonteq Securities AG’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-60,000
Closed -$603K – 1284
2022
Q2 		$603K Hold
60,000
– – 0.02% 358
2022
Q1 		$743K Sell
60,000
-40,000
-40% -$618K 0.03% 353
2021
Q4 		$2.29M Buy
+100,000
New +$2.37M 0.08% 200

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's AUPH Position: Q2 2026 in Review

Leonteq Securities AG increased its Aurinia Pharmaceuticals (AUPH) stake by 3,923% in Q2 2026, buying an estimated $29.5K and bringing the position to 1,891 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #892.

Leonteq Securities AG first reported a position in AUPH in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.62M in Q4 2021. 279 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Leonteq Securities AG held 1,891 shares of Aurinia Pharmaceuticals worth $32.1K as of Q2 2026.
  • Leonteq Securities AG bought 1,844 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $29.5K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #892 holding.
  • Leonteq Securities AG first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Leonteq Securities AG's Aurinia Pharmaceuticals position peaked at $3.62M in Q4 2021.
  • 279 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.